- Home
- HCM vs GRAL Comparison
HCM vs GRAL Comparison
Compare HCM & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- GRAL
- Stock Information
- Founded
- HCM 2000
- GRAL 2016
- Country
- HCM Hong Kong
- GRAL United States
- Employees
- HCM N/A
- GRAL N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- GRAL
- Sector
- HCM Health Care
- GRAL
- Exchange
- HCM Nasdaq
- GRAL NYSE
- Market Cap
- HCM 2.3B
- GRAL 1.8B
- IPO Year
- HCM N/A
- GRAL N/A
- Fundamental
- Price
- HCM $16.11
- GRAL $40.73
- Analyst Decision
- HCM Hold
- GRAL Hold
- Analyst Count
- HCM 1
- GRAL 2
- Target Price
- HCM $19.00
- GRAL $16.00
- AVG Volume (30 Days)
- HCM 71.4K
- GRAL 1.9M
- Earning Date
- HCM 03-19-2025
- GRAL 02-20-2025
- Dividend Yield
- HCM N/A
- GRAL N/A
- EPS Growth
- HCM N/A
- GRAL N/A
- EPS
- HCM N/A
- GRAL N/A
- Revenue
- HCM $610,806,000.00
- GRAL $125,595,000.00
- Revenue This Year
- HCM N/A
- GRAL $35.17
- Revenue Next Year
- HCM $15.89
- GRAL $16.85
- P/E Ratio
- HCM N/A
- GRAL N/A
- Revenue Growth
- HCM N/A
- GRAL 34.90
- 52 Week Low
- HCM $12.84
- GRAL $12.33
- 52 Week High
- HCM $21.92
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- HCM 68.69
- GRAL N/A
- Support Level
- HCM $13.58
- GRAL N/A
- Resistance Level
- HCM $13.96
- GRAL N/A
- Average True Range (ATR)
- HCM 0.31
- GRAL 0.00
- MACD
- HCM 0.34
- GRAL 0.00
- Stochastic Oscillator
- HCM 89.84
- GRAL 0.00
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.